A commercial-stage medical technology company focused on developing, manufacturing, and commercializing minimally invasive solutions to meet the distinct uterine healthcare needs of women. We have established a broad product line of commercially available, minimally invasive alternatives to hysterectomy, which are designed to address the most common causes of abnormal uterine bleeding (AUB) in most uterine anatomies.
Lead Underwriter
J.P. Morgan Securities LLC, Piper Sandler & Co, SVB Leerink LLC, UBS Investment Bank
